At Medicinal Organic Cannabis, each cannabis flower is given the care it deserves at the hands of a passionate team that strive to ensure medical cannabis is available to everyone who needs it.

Medicinal Organic Cannabis: the 21st century face of well-being.

Medicinal Organic Cannabis is a multinational cannabis accelerator and aggregator. The Company has strategic partnerships with leading global cannabis cultivators, manufacturers and producers. We offer a proven, sustainable, stream of high quality products available for wholesale and retail.

Medicinal Organic Cannabis’s target audience is a rapidly growing global market of people who seek wellness and relief from illness and an enhanced quality of life. To best understand why cannabis is such an important medicine please start with the endocannabinoid system and learning about the 'entourage effect'.

Medicinal Organic Cannabis Australia (MOCA)

MOCA - Australia's first Medical Organic Cannabis Company

Medicinal Organic Cannabis Australia (MOCA) organic CBG (Cannabigerol) is ready for harvest mid October 2021

Organic CBG produced by Medicinal Organic Cannabis Australia.

Our beautiful organic CBG flowers scheduled for harvest mid October 2021

MOCA is very proud to announce that our fully organically grown crop of Cannabigerol (CBG) is approaching harvest in mid October 2021.

Cannabigerol (CBG) is one of over 120 types of cannabinoids obtained from the cannabis plant.

Many have referred to CBG as the the next wave of medical cannabis that is about to gain in popularity as it is considered as the mother of all cannabinoids. Other cannabinoids are derived from cannabigerolic acid (CBGA), an acidic form of CBG.

CBG is processed by the body’s endocannabinoid system. The endocannabinoid system is made up of molecules and receptors in our bodies that are responsible for keeping our bodies in an optimal state.

When cannabis is harvested, dried and processed, in fact, the presence of this substance is detectable only in very small percentages (sometimes less than 1%), which is why it has not received particular attention compared to other substances.

Recently, however, it has been discovered that CBG is present in high percentages in the cannabis plant when it is at the beginning of the flowering phase and that it is the first substance to develop in the plant (in the acid form CBGA).

But not only that, it seems that the birth of THC, CBD and many other cannabinoids derives from CBG.

In the past, therefore, CBG was mainly known as a "minor cannabinoid", but today it has earned the nickname "cannabis stem cell".

In fact, as the plant matures, CBGA transforms into THCA, CBDA and CBCA.

When the plant is harvested and dried and manufactured, the action of heat generates a phenomenon called decarboxylation, which transforms CBGA derivatives into non-acid derivatives, namely THC, CBD and another hundred cannabinoids.

The production difficulties of CBG makes it very scarce. It’s much harder to produce than other cannabinoids like THC and CBD. Since CBG shares many similarities with CBD, manufacturers would rather produce CBD.

CBG has a host of promising potential benefits and more research is being done into easing the production and availability of the cannabinoid. CBG is growing in popularity as a result of the host of potential benefits the cannabinoid has to offer.

Cannabigerol is not scheduled by the UN Convention on Psychotropic Substances.

See overview of CBG research on this link and a literature overview of Cannabigerol on this link

Cannabigerol organically grown by Organic CBG produced by Medicinal Organic Cannabis Australia.

Cannabigerol organically grown by Medicinal Organic Cannabis Australia.

Uses for Medical Cannabis

In Australia, The TGA Special Access Schemes recognise that cannabis medications, while unapproved by the TGA due to insufficient efficacy and safety data, may have benefit for the following conditions:

  • chemotherapy-induced nausea and vomiting

  • refractory paediatric epilepsy

  • palliative care indications

  • cancer pain

  • neuropathic pain

  • spasticity from neurological conditions

  • anorexia and wasting associated with chronic illness (such as cancer)

Around the world, patients are seeking innovative emerging medical solutions to restore health and alleviate sickness. We supply international markets with high quality, sustainable, organically grown cannabis medication. Learn about the discovery as cannabis as a medicine in modern times and its re-emergence in medicine.

Medicinal Organic Cannabis is partnered with global online leader, OrganicMarijuana.com. This partnership gives Medicinal Organic Cannabis access to a powerful web platform focused on international markets.

Our focus is on organic cannabis and marijuana products, our view is on an international market. Together with our partners, we work with cultivation facilities and manufacturing labs, who produce cannabis in countries including Canada, Italy, Israel, Jamaica, New York, Los Angeles, and Washington.

Manufacturer and Wholesaler of Organic CBD

Organic CBD Australia
Careful consideration and selection of organic flowers for our CBD products

Our direct involvement in cultivation of organic hemp and cannabis allows MOCA to ensure that all of our products are grown and produced in accordance with our protocols and specifications. At the heart of our hemp farms is a holistic organic CBD cultivation to ensure that our customers and patients receive the best medicine possible.

Access the MOCA Product Portal

Register to gain access to view our product range, product specifications and pricing.

Service for Medical Practitioners, Hospitals and Pharmacies within Australia and approved businesses and individuals outside of Australia. Registration is free and easy and review is within 24-48 hours from registration.

Medicinal Organic Cannabis Australia (MOCA) Pty Ltd, based in Sydney Australia.

MOCA is a privately held company and can entertain investment from 'Sophisticated Investors'.

Here you will find a presentation on MOCA for review.

If you satisfy the Sophisticated Investor condition, you can complete an Sophisticated Investor Declaration.

You submit an application for shares as an investor in Medicinal Organic Cannabis Australia (MOCA).

Medical Cannabis Patient Intake Form. MOCA collaborates with medical practitioners who are specialised in most states in Australia. To assist our website visitors, we can connect people seeking medical cannabis medications with specialised doctors who charge for their services.

We collect information that is sent to approved cannabis doctors who are able to prescribe all Australian Therapeutic Goods Administration (TGA) approved cannabis medicine. Medical Cannabis patient privacy policy

Participate in International Research on CBD usage and consumption and the effects on the endocannabinoid system with the University of Paris on Survey for health supplements completely anonymous questionnaire

Medicinal Organic Cannabis business model leverages strategic scientific research partnerships with high levels of technical and procedural knowledge in cultivating, processing, and producing medicinal organic cannabis products.

Experience

Medicinal Organic Cannabis has broad experience worldwide with a team of professionals on the ground in 5 countries.

We deliver products to patients and consumers around the globe. Our cultivation facilities are among the most advanced in the world.

Precision

Medicinal Organic Cannabis is the first organic medical cannabis producer to supply cannabis flower and extracts. All of our products are produced with meticulous care to ensure the highest quality, consistency and purity for our patients.

Research

We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.

Care

Medicinal Organic Cannabis takes tremendous pride in our customer service, and medical practitioner interaction. We place great importance on providing the best possible organic therapeutic products for our patients.



Medicinal Organic Cannabis

Our Vision is a world where wellness abounds.

We take pride in helping facilitate the medical healing properties of the cannabis plant to become researched, understood, and integrated into medical and wellness industries worldwide.



Core business Organic Cannabis Wholesale and supply

  • Cultivation and sourcing organic and non-organic cannabis flowers and biomass for manufacture into medical products.

  • Producing, distributing and importing a range of products under our brands.

  • Supplying cannabis based medical products use in treating patients suffering from clinical conditions.

  • Wholesale supply of cannabis biomass and flowers.

  • Scientific research of cannabinoid based medical products for treating chemotherapy-induced nausea and vomiting, epilepsy, multiple sclerosis, chronic non-cancer pain and palliative care.

  • Research, cultivation and manufacture of THC rich products for international wholesale.

An international scientific team supports Medicinal Organic Cannabis, allowing us to bring the best products to global markets. Ongoing multinational best practices research informs the company’s decisions into products, markets, and cannabis cultivation methods.

Medicinal Organic Cannabis International Operations

At Medicinal Organic Cannabis, we place significant importance on People, Planet, and Profit. Fresh polling of 600 pension funds, endowments, and sovereign wealth funds with $21.5 trillion (U.S.) in assets around the globe has made it clear that the majority of large investors see putting money into companies that ignore environmental, social and governance indicators as a material risk to their portfolios. Medicinal Organic Cannabis is responsible to our physical and social environments while providing excellent products to consumers. Interestingly, research from Hill+Knowlton found 57% of medical patients prefer organic cannabis. The survey found 43% of recreational users had the same preference. Reference

The cannabis industry is evolving very rapidly as such; we are in the vertically integrated cannabis category. This approach allows us to select from the best-priced products that meet our standards and make available to a burgeoning market. It allows Medicinal Organic Cannabis to determine the most desirable and marketable products without additionally investing in manufacturing products. With the ability to reduce the price of product, Medicinal Organic Cannabis is able to capitalize by providing consumers with large savings. See a brief presentation of MOCA

Mission & Objectives

Mission

To become a global leader in the development & commercialisation of organic cannabis therapeutic products for a variety of clinical indications by growing unique strains of organic cannabis to supply established, existing and newly regulated markets

Business Objectives

Our focus is being a leading international producer, & wholesaler of organic cannabis based products.

Objectives include:

      • Grow our organic cannabis product range.

      • Grow our global client base.

      • Cater to emerging markets.

      • Expand our cultivation bases exponentially to cater to international demand.

Our new website is now live online and you can see it as we continue to build the content specific to Organic CBD stay in touch as we develop the site further in the coming months.